Health and Fitness Health and Fitness
Thu, October 13, 2011
Wed, October 12, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Financial Statement 10/11
Tue, October 11, 2011
[ Tue, Oct 11th 2011 ] - Market Wire
Aetna??Michael Elliott???????
Mon, October 10, 2011
Sun, October 9, 2011
Sat, October 8, 2011
Fri, October 7, 2011
Thu, October 6, 2011
Wed, October 5, 2011
Tue, October 4, 2011
Mon, October 3, 2011
[ Mon, Oct 03rd 2011 ] - Market Wire
Medwell Capital to Adopt IFRS
Sun, October 2, 2011
Sat, October 1, 2011
Fri, September 30, 2011
Thu, September 29, 2011
Wed, September 28, 2011
Tue, September 27, 2011
Mon, September 26, 2011
Sat, September 24, 2011
Fri, September 23, 2011
Thu, September 22, 2011
Wed, September 21, 2011
Tue, September 20, 2011

Law Office of Brodsky & Smith, LLC Announces Investigation of Pharmaceuticals Product Development, Inc.


//health-fitness.news-articles.net/content/2011/ .. -of-pharmaceuticals-product-development-inc.html
Published in Health and Fitness on Monday, October 3rd 2011 at 21:20 GMT by Market Wire   Print publication without navigation


BALA CYNWYD, Pa.--([ BUSINESS WIRE ])--Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors ofPharmaceuticals Product Development, Inc. (aPPDa or the aCompanya) (Nasdaq: PPDI) relating to the proposed acquisition by an affiliate of The Carlyle Group and Hellman & Friedman.

Under the terms of the offer PPD shareholders would receive $33.25 in cash for each share of PPD stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of PPD for not acting in the Companya™s shareholders' best interests in connection with the sale process. The transaction may undervalue the Company as an analyst has set a price target of $38.00 per PPD share.

If you own shares of PPD stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at [ investorrelations@brodsky-smith.com ], visiting [ http://brodsky-smith.com/335-ppdi-pharmaceutical-product-development-inc.html ], or by calling toll free 877-LEGAL-90.


Publication Contributing Sources